Sunshine Biopharma (SBFM) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Sunshine Biopharma (SBFM) over the last 11 years, with Q3 2025 value amounting to $6.7 million.
- Sunshine Biopharma's Total Current Liabilities rose 4687.75% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 4687.75%. This contributed to the annual value of $6.3 million for FY2024, which is 1374.46% up from last year.
- Per Sunshine Biopharma's latest filing, its Total Current Liabilities stood at $6.7 million for Q3 2025, which was up 4687.75% from $5.6 million recorded in Q2 2025.
- Over the past 5 years, Sunshine Biopharma's Total Current Liabilities peaked at $6.9 million during Q4 2022, and registered a low of $91229.0 during Q4 2021.
- In the last 5 years, Sunshine Biopharma's Total Current Liabilities had a median value of $5.1 million in 2023 and averaged $3.8 million.
- Per our database at Business Quant, Sunshine Biopharma's Total Current Liabilities crashed by 9132.23% in 2021 and then soared by 749738.02% in 2022.
- Quarter analysis of 5 years shows Sunshine Biopharma's Total Current Liabilities stood at $91229.0 in 2021, then surged by 7497.38% to $6.9 million in 2022, then decreased by 19.9% to $5.6 million in 2023, then rose by 13.74% to $6.3 million in 2024, then increased by 5.33% to $6.7 million in 2025.
- Its Total Current Liabilities stands at $6.7 million for Q3 2025, versus $5.6 million for Q2 2025 and $5.8 million for Q1 2025.